Concepedia

Publication | Open Access

Effects of Topical and Subconjunctival Bevacizumab in High-Risk Corneal Transplant Survival

91

Citations

39

References

2010

Year

Abstract

Subconjunctival bevacizumab may offer an adjunctive measure to conventional therapies in preventing graft rejection in high-risk corneal transplantation.

References

YearCitations

Page 1